Our result showed that ICAM-1 expression was significantly augmented after treatment with the unconditioned protein supplemented at the beginning of ischemia and even more when exposed to hypoxia-preconditioned α-Syn (Figure 6A) in comparison to nontreated ischemic or control cells. This evidence concerns the gene ICAM1 and ischemia.